Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus

LG Chem

Status: Unknown

Conditions: Type 2 Diabetes Mellitus

Study type: Observational

Funder types: Industry

Identifiers

NCT05281029

LG-DPOS002

Details and patient eligibility

About

The aim of this study is to evaluate safety and effectiveness of treatment with gemigliptin for 24 weeks in Korean patients aged ≥ 65 years with type 2 diabetes mellitus in routine clinical settings

Enrollment: 3,000 estimated patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who have been started on gemigliptin in accordance with the approved label and who have signed on the consent form

Exclusion criteria

• Patients with previous exposure to gemigliptin and current participation in clinical trials